BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.
Rheumatoid arthritis studies in Phase III trials generally rely on radiographs to determine the imaging endpoints. In addition, MRI has become an essential imaging modality for the assessment of rheumatoid arthritis patients, particularly in the Phase II setting. BioClinica has helped support image collection and central reads in clinical trials for five separate FDA-approved therapeutic agents for the treatment of rheumatoid arthritis, all of which are currently being marketed and used worldwide.
“BioClinica understands the critical level of detail that is required to ensure success in rheumatoid arthritis clinical trials,” said Mark L. Weinstein, President and CEO of BioClinica. “RA is one of several key therapeutic areas in which we have project management teams dedicated only to that specialty. This model ensures that our clients obtain the knowledge, expertise and talent that will help their trial to succeed, and it increases the efficiency and success of their clinical trials programs, from start-up to submission.”
BioClinica is an industry leader in supporting international multi-center clinical trials in the therapeutic areas of oncology, cardiology, neurology, and musculoskeletal diseases, including rheumatoid arthritis, osteoporosis and osteoarthritis. The company’s therapeutically-specialized project management teams coordinate all functions of the medical image data management. Each team includes scientific and medical staff, a network of world-renowned key opinion leaders and an extensive roster of collaborative consultants. With experience gained in more than 800 imaging studies of all sizes, these experts can help to maximize the efficiency and quality of any therapeutic clinical trial.
Symposium Details
Focusing on “Medical Imaging for Rheumatoid Arthritis in Clinical Trials – Successful Trial Design and Delivery,” the symposium will be a series of presentations with discussions on relevant topics, including:
- Designing a Successful Radiographic
- MRI Scoring
- Campaign Designs
- Handling of Missing Information
- Evaluating and Interpreting Mock Read Results
Valuable insight on these topics will be delivered by industry leaders, including:
- Désirée van der Heijde, MD, Ph.D., Professor of Rheumatology, Leiden University Medical Center, Imaging Rheumatology, BV, Leiden, Netherlands
- Robert Landewé, MD, Ph.D., Professor of Rheumatology, University Hospital, Maastricht, Maastricht, Netherlands
- Ali Guermazi, MD, Section Chief, Musculoskeletal Director, Quantitative Imaging Center (QIC), Department of Radiology, Boston University Medical Center
The event will be held at the ACE Conference Center in Lafayette PA, starting at 8:00 a.m. EST on November 18, 2009. Pharmaceutical and device company personnel, medical imaging executives, and partners are invited to attend this complementary symposium. For more details, please visit: https://clario.com/
BioClinica second quarter service revenues increase 8.7% to $16.9 million